Literature DB >> 2592885

Risk factors in chronic obstructive pulmonary malfunction and "chronic bronchitis" symptoms in Beijing district: a joint study between Japan and China.

S Yamaguchi1, K Kano, N Shimojo, K Sano, X P Xu, H Watanabe, M Kameyama, M J Santamaria, S J Liu, L H Wang.   

Abstract

A cross sectional study of risk factors in respiratory diseases was carried out in August 1986, in Beijing, China. Inhabitants greater than or equal to 40 years old were selected at random from a rural area, a residential area and an industrial area, using a two stage sampling method. The analysis presented here is based on the sample population of adults who (1) were prepared to be interviewed, using the British Medical Research Council's questionnaire translated into Chinese (n = 3423) and (2) had lung function measurements at the same time (n = 3373). Obstructive lung disease was defined as forced expiratory volume in 1s (FEV1) less than 68% of forced vital capacity (FVC). Seven variables were considered as potential risk factors or confounding factors: area of residence, sex, age, cigarette smoking, history of respiratory disease, socio-economic status and familial component. A modified binary variable regression method developed by Feldstein was used for the adjustment of rate ratios. The adjusted prevalence of obstructive lung disease was highest in the rural area and lowest in the residential area(s). An increase in age, cigarette smoking, low socio-economic status and positive history of respiratory diseases were associated with significantly higher rates of impaired pulmonary function. The other measured factors did not appear to be related to impaired pulmonary function.

Entities:  

Mesh:

Year:  1989        PMID: 2592885      PMCID: PMC1052783          DOI: 10.1136/jech.43.1.1

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  9 in total

1.  The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.

Authors:  C M FLETCHER; P C ELMES; A S FAIRBAIRN; C H WOOD
Journal:  Br Med J       Date:  1959-08-29

2.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

3.  Azathioprine-induced acute pancreatitis.

Authors:  H Kawanishi; E Rudolph; F E Bull
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

4.  Respiratory disease in young adults: influence of early childhood lower respiratory tract illness, social class, air pollution, and smoking.

Authors:  J R Colley; J W Douglas; D D Reid
Journal:  Br Med J       Date:  1973-07-28

5.  Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium.

Authors:  C M Fletcher; N B Pride
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

6.  Genetic factors in chronic obstructive lung disease.

Authors:  H A Menkes; B H Cohen; D A Levy; P Kreiss; S Permutt; J Tielsh
Journal:  Bull Eur Physiopathol Respir       Date:  1980

7.  Multiple factors in airways obstruction.

Authors:  B H Cohen; H A Menkes; W B Bias; G A Chase; E L Diamond; C G Graves; D A Levy; M B Meyer; S Permutt; M S Tockman
Journal:  Chest       Date:  1980-02       Impact factor: 9.410

8.  A comparison of two respiratory symptoms questionnaires.

Authors:  W W Holland; J R Ashford; J R Colley; D C Morgan; N J Pearson
Journal:  Br J Prev Soc Med       Date:  1966-04

9.  Social and environmental factors in respiratory disease. A preliminary report.

Authors:  J R Colley; W W Holland
Journal:  Arch Environ Health       Date:  1967-01
  9 in total
  2 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

2.  Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study.

Authors:  A M Menezes; C G Victora; M Rigatto
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.